215 related articles for article (PubMed ID: 19389507)
1. Intercellular centrosome number is correlated with the copy number of chromosomes in bladder cancer.
Yamamoto Y; Eguchi S; Junpei A; Nagao K; Sakano S; Furuya T; Oga A; Kawauchi S; Sasaki K; Matsuyama H
Cancer Genet Cytogenet; 2009 May; 191(1):38-42. PubMed ID: 19389507
[TBL] [Abstract][Full Text] [Related]
2. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.
Yamamoto Y; Matsuyama H; Furuya T; Oga A; Yoshihiro S; Okuda M; Kawauchi S; Sasaki K; Naito K
Clin Cancer Res; 2004 Oct; 10(19):6449-55. PubMed ID: 15475431
[TBL] [Abstract][Full Text] [Related]
3. Centrosome amplification as a putative prognostic biomarker for the classification of urothelial carcinomas.
Yamamoto Y; Misumi T; Eguchi S; Chochi Y; Kitahara S; Nakao M; Nagao K; Hara T; Sakano S; Furuya T; Oga A; Kawauchi S; Sasaki K; Matsuyama H
Hum Pathol; 2011 Dec; 42(12):1923-30. PubMed ID: 21683985
[TBL] [Abstract][Full Text] [Related]
4. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer.
Yamamoto Y; Matsuyama H; Chochi Y; Okuda M; Kawauchi S; Inoue R; Furuya T; Oga A; Naito K; Sasaki K
Cancer Genet Cytogenet; 2007 Apr; 174(1):42-7. PubMed ID: 17350465
[TBL] [Abstract][Full Text] [Related]
6. [Centrosome isolation from cultured bladder cancer cells--p53 mutation and centrosome hyperamplification].
Kawamura K; Moriyama M; Suga K; Shiba N; Tanaka T; Ikeda R; Suzuki K
Hinyokika Kiyo; 2003 Feb; 49(2):69-74. PubMed ID: 12696185
[TBL] [Abstract][Full Text] [Related]
7. Centrosome hyperamplification and chromosomal damage after exposure to radiation.
Kawamura K; Fujikawa-Yamamoto K; Ozaki M; Iwabuchi K; Nakashima H; Domiki C; Morita N; Inoue M; Tokunaga K; Shiba N; Ikeda R; Suzuki K
Oncology; 2004; 67(5-6):460-70. PubMed ID: 15714003
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer.
Ohta JI; Miyoshi Y; Uemura H; Fujinami K; Mikata K; Hosaka M; Tokita Y; Kubota Y
Clin Cancer Res; 2001 Aug; 7(8):2463-7. PubMed ID: 11489827
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer.
Sauter G; Moch H; Gasser TC; Mihatsch MJ; Waldman FM
Cytometry; 1995 Sep; 21(1):40-6. PubMed ID: 8529469
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
12. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters.
Gallucci M; Guadagni F; Marzano R; Leonardo C; Merola R; Sentinelli S; Ruggeri EM; Cantiani R; Sperduti I; Lopez Fde L; Cianciulli AM
J Clin Pathol; 2005 Apr; 58(4):367-71. PubMed ID: 15790699
[TBL] [Abstract][Full Text] [Related]
13. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
14. Centrosome amplification, chromosome instability and cancer development.
Fukasawa K
Cancer Lett; 2005 Dec; 230(1):6-19. PubMed ID: 16253756
[TBL] [Abstract][Full Text] [Related]
15. Induction of centrosome amplification and chromosome instability in p53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE).
Shinmura K; Iwaizumi M; Igarashi H; Nagura K; Yamada H; Suzuki M; Fukasawa K; Sugimura H
J Pathol; 2008 Nov; 216(3):365-74. PubMed ID: 18788085
[TBL] [Abstract][Full Text] [Related]
16. Spindle assembly checkpoint and centrosome abnormalities in oral cancer.
Thirthagiri E; Robinson CM; Huntley S; Davies M; Yap LF; Prime SS; Paterson IC
Cancer Lett; 2007 Dec; 258(2):276-85. PubMed ID: 17959302
[TBL] [Abstract][Full Text] [Related]
17. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
18. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
Mahlamäki EH; Bärlund M; Tanner M; Gorunova L; Höglund M; Karhu R; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):353-8. PubMed ID: 12378529
[TBL] [Abstract][Full Text] [Related]
19. AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells.
Zhu J; Abbruzzese JL; Izzo J; Hittelman WN; Li D
Cancer Genet Cytogenet; 2005 May; 159(1):10-7. PubMed ID: 15860351
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.
Lingle WL; Lukasiewicz K; Salisbury JL
Adv Exp Med Biol; 2005; 570():393-421. PubMed ID: 18727509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
